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Background: Fetal growth restriction (FGR) is associated with increased infant mortality rates and ill-health in adulthood.
Evaluation of fetal growth requires ultrasound. As a result, ultrasound-assisted evaluations of causes of FGR in
malaria-endemic developing countries are rare. We aimed to determine factors associated with indicators of abnormal
fetal growth in rural lowland Papua New Guinea (PNG).
Methods: Weights and growth of 671 ultrasound-dated singleton pregnancies (<25 gestational weeks) were
prospectively monitored using estimated fetal weights and birthweights. Maternal nutritional status and
haemoglobin levels were assessed at enrolment, and participants were screened for malaria on several occasions.
FGR was suspected upon detection of an estimated fetal weight or birthweight <10th centile (small-for-gestational
age) and/or low fetal weight gain, defined as a change in weight z-score in the first quartile. Factors associated
with fetal weight and fetal weight gain were additionally assessed by evaluating differences in weight z-scores
and change in weight z-scores. Log-binomial and linear mixed effect models were used to determine factors
associated with indicators of FGR.
Results: SGA and low weight gain were detected in 48.3% and 37.0% of pregnancies, respectively. Of participants,
13.8%, 21.2%, and 22.8% had a low mid-upper arm circumference (MUAC, <22 cms), short stature (<150 cms)
and anaemia (haemoglobin <90 g/L) at first antenatal visit. 24.0% (161/671) of women had at least one malaria
infection detected in peripheral blood. A low MUAC (adjusted risk ratio [aRR] 1.51, 95% CI 1.29, 1.76, P < 0.001),
short stature (aRR 1.27, 95% CI 1.04, 1.55, P = 0.009), and anaemia (aRR 1.27, 95% CI 1.06, 1.51, P = 0.009) were associated
with SGA, and a low body mass index was associated with low fetal weight gain (aRR 2.10, 95% CI 1.62, 2.71, P < 0.001).
Additionally, recent receipt of intermittent preventive treatment in pregnancy was associated with increased
weight z-scores, and anaemia with reduced change in weight z-scores. Malaria infection was associated with SGA
on crude but not adjusted analyses (aRR 1.13, 95% CI 0.95, 1.34, P = 0.172).
Conclusion: Macronutrient undernutrition and anaemia increased the risk of FGR. Antenatal nutritional
interventions and malaria prevention could improve fetal growth in PNG.
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Fetal growth restriction (FGR) is associated with growth
faltering in early childhood, increases infant mortality
rates, and predisposes to ill-health in adulthood [1-4].
The burden of FGR and its potential consequence, low
birthweight (LBW, <2,500 g), is estimated highest in
low-income countries (LIC), where maternal undernutri-
tion, short stature, malaria, anaemia, and HIV are im-
portant risk factors and pregnancy rates are high [3,5-7].
Researching causes of FGR in LICs is challenging be-
cause ultrasound for pregnancy dating and fetal growth
monitoring is not yet widely available. Alternative esti-
mators of gestational age such as last menstrual period
are frequently unreliable [8], and late presentation to
antenatal clinic precludes dating based on early preg-
nancy biometric measurements [9]. A number of studies
evaluated factors associated with measuring small-for-
gestational-age (fetal size/weight <10th centile of a given
weight standard, SGA) [3], commonly used as an indica-
tor of FGR in epidemiological studies, yet few used
ultrasound to determine gestational age and to evaluate
fetal growth in utero.
Sequestration of Plasmodium falciparum-infected eryth-
rocytes in the placental intervillous space is an important
cause of LBW, most frequently due to FGR [10]. A small
number of ultrasound studies have evaluated the effect of
malaria infection, and at times additional factors such as
maternal nutritional status, on fetal growth. In Thailand
and Brazil, P. falciparum and P. vivax infection in early
pregnancy was associated with lower fetal biometric mea-
surements [11,12], while in Tanzania, third trimester fetal
growth alterations were observed following malaria infec-
tion before 20 weeks’ gestation [13]. Infections tended to
have most impact on growth in late second and early third
trimester in a Kenyan cohort [14]. In the Democratic Re-
public of Congo, a low mid-upper arm circumference
(MUAC), short stature, malaria and anaemia were associ-
ated with SGA, [15], while in Thailand a low body mass
index (BMI) was associated with reduced biparietal diam-
eter z-scores [11]. In another Congolese cohort, under-
nourished women were at increased risk of SGA due to P.
falciparum infection [16]. Overall, the number of ultra-
sound studies evaluating the role of undernutrition and
malaria as causes of suboptimal fetal growth in LICs is
limited, in particular outside of sub-Saharan Africa and
South East Asia.
Antenatal care is a window of opportunity to improve
fetal outcomes. Mapping principal causes of FGR in
LICs provides a platform to develop, test and implement
prenatal interventions to improve fetal growth and re-
duce LBW. We evaluated factors associated with FGR
in fetuses of women co-enrolled in a randomised con-
trolled trial evaluating intermittent preventive treat-
ment of malaria in pregnancy (IPTp) in Papua NewGuinea (PNG) (NCT01136850) [17]. In the trial, IPTp
reduced LBW by 26%, and reduced preterm birth by
38% [17].
Methods
We recruited women at first prenatal visit in Madang,
PNG, between November 2009 and August 2012. The
study area is characterised by year-round malaria trans-
mission (P. falciparum and P. vivax) [18], and LBW is
common (17%) [17].
Participants were co-enrolled in a trial that investi-
gated the efficacy of monthly IPTp with azithromycin
and sulphadoxine-pyrimethamine (SP), given from sec-
ond trimester, compared to a single treatment course of
SP plus chloroquine at their first prenatal visit, followed
by monthly placebo doses (regimen designed to mimic
current PNG prevention of malaria in pregnancy policy
whilst allowing for participant blinding) [17]. Eligibility
criteria included age 16–49 years, singleton pregnancy,
and no known co-morbidities. Only trial participants
with a dating ultrasound <24 gestational weeks were in-
cluded [9]. Women with adverse pregnancy outcomes
(miscarriage, stillbirth, congenital abnormality) were ex-
cluded from analyses.
At enrolment maternal sociodemographic and clinical
characteristics were evaluated, maternal anthropometric
measurements were taken, and women were screened
for anaemia (haemoglobin [Hb] <90 g/L; HemoCue,
Sweden). Anaemia was treated with iron/folate supple-
ments and the anthelmintic albendazole, and malaria with
quinine (first trimester) or artemether-lumefantrine, ac-
cording to national guidelines, and insecticide-treated bed
nets were provided when available.
A dating ultrasound scan (Logiqbook XP, General
Electric Medical Systems, UK) was performed within a
week of enrolment using crown-rump length or head
circumference (femur length if unavailable) to estimate
GA [9]. To monitor fetal growth, women were scheduled
for ultrasound scans every six weeks and followed up
until birth when birthweight (BW) was measured to the
nearest 10 g (Cupid digital scale, Charder Medical,
Taiwan). Birth anthropometric measurements were in-
cluded in analyses only if obtained within 24 hours of
delivery. Ultrasound measurements were performed by
two clinicians (MO, HWU) and fetal weights (EFW)
were estimated from fetal head and abdominal circum-
ference and femur length using standard formulae [19].
A random selection of image stills (10%) was sent for
quality control to JW. Women with an abnormal scan
were referred to the local obstetrician for further
management.
Maternal blood (enrolment, delivery, IPTp visits, pas-
sive case detection visits), and placental biopsies were
used to characterise malarial infection. Thick smears
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200 leukocytes (WBC) (or per 500 if <10 parasites/200
WBCs), assuming 8000 WBCs/μL of blood. Slides were
declared negative if no parasite was seen in 200 oil-
immersion fields at 1000 times magnification following
reads by two microscopists. In addition, quantitative
real-time polymerase chain reaction (qPCR) was per-
formed on maternal blood [20]. Placental malaria was
classified as active (presence of parasitised cells) and past
(hemozoin only) [21].
Given the detection of FGR is challenging and not all
infants measuring are SGA are growth-restricted we
opted to use two indicators of FGR, SGA (cross-sec-
tional assessment) and low fetal weight gain (longitu-
dinal assessment) [13]. Suboptimal fetal growth was
suspected upon detection of an EFW or BW below the
10th centile (SGA) of the Hadlock standard (10th centiles
of ultrasound-estimated and birthweight-derived stan-
dards are similar at term) [19,22], and/or observation of
low fetal weight gain, defined as a change in weight z-
score (Δz) below the 25th centile of the overall distribu-
tion of Δz, using weight measurements obtained >14 days
apart. Factors associated with fetal weight and fetal
weight gain were additionally assessed by evaluating dif-
ferences in continuous outcomes measures, namely
weight z-scores and Δz.
Maternal macronutrient undernutrition was defined as
low body mass index (BMI; <18.5 kg/m2) or low MUAC
(<22 cm) at enrolment, and short stature as maternal
height <150 cm [23]. Weekly maternal weight gain was
classified as low if in the first quartile for a subset of
women with complete maternal weight gain data.
In addition to evaluating the effect of P. falciparum
and P. vivax infection at enrolment (defined as positivity
by light microscopy and/or qPCR) we generated weight
measurement-specific time-dependent variables of infec-
tion to account for time and number of infections in rela-
tion to each weight measurement by pooling all available
malaria diagnosis data (light microscopy, qPCR, histology)
[16]. ‘Recent infections’ were defined as infection during
the interval from six weeks prior to the day of fetal weight
measurement and ‘any infection’ as infection at any time
up until and including the day of weight measurement.
Women with active placental malaria were coded as a hav-
ing had a ‘recent infection’ for the BW measurement,
while women with past placental malaria were coded as
having had an infection prior to or at enrolment provided
they were peripheral blood negative throughout. ‘Recent
IPTp’ was defined as IPTp ≤ 6 weeks before a weight
measurement.
Statistical analyses were performed using Stata 12.0
(StataCorp, USA). For binary outcomes log-binomial
regression models were fitted to calculate risk ratios
(RR) and were estimated using generalised estimatingequations (GEE) with an exchangeable working correl-
ation structure. Linear mixed effect (LME) models with
a restricted maximum likelihood were used to report
mean differences in z-scores and Δz. Both GEE and
LME account for repeat measurements of indicators of
FGR within individuals. Covariates associated with the
outcome measure on univariate analysis (P <0.05) were
used to generate adjusted RRs and mean differences.
Interaction terms for indicators of maternal undernutri-
tion (and gravidity) and malaria were included in log-
binomial models to assess the potential effect measure
modification of the malaria-SGA relationship by nutri-
tional status and number of previous pregnancies, de-
fined a priori as P <0.15 of the interaction term.
All participants provided written informed consent.
The research was approved by the PNG Institute of
Medical Research, the PNG Medical Research Advisory
Council and the Melbourne Health Human Research
Ethics Committee.
Results
Of 2793 women enrolled into the parent trial 1863 had
no, or late, dating ultrasound scan and 75 were with-
drawn for trial reasons, leaving 855 to be enrolled in this
ultrasound study. For 122 women pregnancy outcomes
were unavailable, 22 suffered a stillbirth, six delivered a
congenitally abnormal neonate, and 34 had suboptimal
fetal biometric measurements. In a final cohort of 671
participants the mean gestational age (GA) (standard de-
viation) at enrolment was 19.6 ± 3.7 weeks. Fifty percent
were primigravid, most lived rurally, and more than half
pursued an income-generating activity (Table 1).
A total of 1504 weight measurements were available
for analysis (median per pregnancy 3, range 1–5; EFW =
893, BW = 611). 91.1% (611/671) of BWs were eligible
for inclusion: the prevalence of LBW was 15.7% (96/611).
Fetuses of 527 women had growth intervals available for
analysis (median: 2, range 1–4, total = 833). Most weight
measurements were obtained in mid-second and late third
trimester (Table 1).
Forty-eight percent of fetuses/newborns (324/671)
measured SGA at least once: 275 on one, 43 on two, and
six on three occasions, most commonly at delivery
(76.9%, 249/324). 37.0% (195/527) of fetuses experienced
low weight gain. Ultrasound detection of SGA or low
weight gain was strongly associated with LBW, reduced
mean birthweights and SGA at birth (Table 2). Primigra-
vidity and GA at weight measurement were associated
with measuring SGA (Table 1).
Of participants, 13.8%, 21.2%, and 22.8% had a low
MUAC, short stature and anaemia (haemoglobin <90 g/L)
at first antenatal visit, respectively (Table 3). A low MUAC
increased the risk of measuring SGA by 50% in both crude
(RR 1.48, 95% CI 1.20, 1.82, P <0.001) and adjusted
Table 1 Characteristics of pregnant women and risk of measuring small-for-gestational age, Madang, PNG, 2009–2012
Characteristic % (N) RRa 95% CI P
Maternal age
16-21 35.9 (241/671) Referent
22-26 36.2 (243/671) 0.85 (0.69, 1.03)
≥27 27.9 (187/671) 0.86 (0.69, 1.07) 0.196
Gravidity
>1 47.9 (320/671) Referent
1 52.1 (351/671) 1.35 (1.13, 1.61) 0.001
Ethnicity
Madang/Morobe 63.5 (426/671) Referent
Other 36.5 (245/671) 0.84 (0.70, 1.02) 0.075
Infant sex
Male 46.3 (307/663) Referent
Female 53.7 (356/663) 1.03 (0.86, 1.22) 0.767
Smoking
No 82.9 (556/671) Referent
Yes 17.1 (115/671) 0.98 (0.79, 1.22) 0.886
Betel nut consumption
No 20.0 (134/669) Referent
Yes 80.0 (535/669) 0.88 (0.72, 1.09) 0.238
Literate
No 8.8 (59/670) Referent
Yes 91.2 (611/670) 1.10 (0.81, 1.49) 0.546
Mother generating income
No 45.5 (298/655) Referent
Yes 54.5 (357/655) 1.04 (0.87, 1.24) 0.689
Partner generating income
No 32.5 (217/667) Referent
Yes 67.5 (450/667) 0.87 (0.73, 1.02) 0.086
Area of residence
Urban 18.5 (124/670) Referent
Peri-urban 23.7 (159/670) 1.15 (0.87, 1.52)
Rural 57.8 (387/670) 1.06 (0.83, 1.37) 0.602
Raised CRP at enrolment (≥5 mg/L)
No 80.0 (392/490) Referent
Yes 20.0 (98/490) 0.89 (0.69, 1.15) 0.367
Gestational week at fetal weight measurementb
22-25 26.3 (395/1,504) Referent
26-29 17.2 (258/1,504) 2.24 (1.16, 4.33)
30-33 11.6 (174/1,504) 4.82 (2.63, 8.81)
34-37 10.0 (151/1,504) 13.1 (7.47, 22.87)
≥38 35.0 (526/1,504) 13.9 (8.20, 23.61) <0.001
Note. RR, risk ratio; CI, confidence interval, CRP, C-reactive protein. SGA was defined as a weight below the 10th centile of the Hadlock standard. P-values are for
comparison across all groups.
a Unadjusted risk ratio.
b Measurement-specific.
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Table 2 Ultrasound detection of SGA and low fetal weight gain, and association with measures at birth
Indicator SGAa Not SGAa P Low fetal weight gainb Normal fetal weight gainb P
LBW 26.5 [18/68] 14.3 [63/441] 0.011 25.5 [12/47] 14.1 [31/206] 0.054
SGA at birth 72.1 [49/68] 44.4 [196/441] <0.001 61.7 [29/47] 46.1 [95/206] 0.054
PTB 8.1 [6/74] 4.7 [22/470] 0.215 11.3 [6/53] 2.8 [6/217] 0.007
Gestational age (wks) 39.4 (35.1-43.1) 39.4 (25.6-43.7) 0.196 39.1 (35.1, 42.1) 39.4 (34.4, 43.4) 0.083
Birthweight (g) 2718 (2612, 2823) 2961 (2916, 3007) <0.001 2737 (2595, 2880) 2969 (2907, 3031) 0.002
Head circumference (cm) 32.5 (32.0, 33.0) 32.9 (32.8, 33.1) 0.101 32.7 (32.1, 33.2) 33.0 (32.7, 33.2) 0.280
Abdominal circumference (cm) 30.9 (30.3, 31.5) 31.8 (31.5, 32.0) 0.007 31.3 (30.4, 32.1) 31.8 (31.5, 32.1) 0.191
Crown-heel length (cm) 46.6 (45.8, 47.5) 47.7 (47.4, 48.1) 0.021 46.8 (45.8, 47.8) 47.4 (47.0, 47.9) 0.245
Ponderal index (g/[length in cm]3) 2.7 (2.6, 2.9) 2.8 (2.7, 2.8) 0.431 2.7 (2.5, 2.9) 2.8 (2.7, 2.9) 0.107
Cord haemoglobin (g/L) 132 (124, 141) 138 (135, 142) 0.178 134 (122, 146) 138.0 (133, 143) 0.500
Note. Values are percent [n], mean (95% confidence interval) or ranks (range). SGA, small-for-gestational-age (<10th percentile of Hadlock standard); P <0.05
highlighted in bold.
a Includes 556 women with ≥ 1 ultrasound-estimated fetal weight.
b Includes 275 women with ≥ 1 growth intervals based on EFW only.
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(Table 3). Equally, maternal short stature was a risk
factor for measuring SGA (aRR 1.27, 95% CI 1.04, 1.55,
P = 0.009). Anaemia at enrolment was also associated
with an increased risk of SGA (aRR 1.29, 95% CI 1.08,
1.54, P = 0.009), and so was low weekly maternal weight
gain (aRR 1.21, CI 95% 1.01, 1.45, P = 0.042) when
assessed in a subset of women. A low enrolment BMI
was associated with low fetal weight gain (aRR 2.08,
95% CI 1.62, 2.68, P <0.001) (Table 4). Recent receipt
of IPTp was associated with increased fetal weight z-
scores (adjusted coefficient 0.16, 95% CI 0.04, 0.27, P =
0.010) (Table 2), and anaemia with reduced weight Δz
(adjusted Δz coefficient −0.18, 95% CI −0.34, −0.03, P =
0.021) (Tables 3,4).
A total of 197 Plasmodium spp. infections were de-
tected in peripheral blood of 161 women (P. falcip-
arum 70.3%, P. vivax 29.7%; median number of
screens per participant: 4 [range 2–5]). Forty-four per-
cent (86/197) of infections were submicroscopic (de-
tected by qPCR only). Most peripheral infections were
detected at enrolment (50.8% [100/197], prevalence
14.9%) and delivery (27.4% [54/197]), and 32 and 44
women had active and past placental infection,
respectively.
A history of ‘any infection’ was significantly associ-
ated with an increased risk of measuring SGA in an
unadjusted model (RR 1.36, 95% CI 1.12, 1.65, P =
0.002) but not in a fully adjusted model (RR 1.13, 95%
CI 0.95, 1.34, P = 0.172) (Table 3). The risk of SGA in-
creased with cumulative infections, but this associ-
ation did not remain significant in adjusted analyses
(Table 3). We did not observe effect measure modifi-
cation of the malaria-SGA relationship by nutritional
status (BMI or MUAC) or primigravidity.Discussion
In a cohort of pregnant PNG women maternal undernu-
trition, short stature and anaemia were associated with
indicators of FGR. Malaria infection prior to a weight
measurement was associated with an increased risk of
SGA in unadjusted but not adjusted analyses. Recent re-
ceipt of IPTp was associated with increased fetal weight
z-scores.
This is the first study to evaluate causes of FGR in a
malaria-endemic region of PNG using ultrasound tech-
nology. Strengths of the study include a large sample
size, sonographic pregnancy dating and availability of in-
formation on potential risk factors for FGR, including
malaria.
This research needs to be interpreted in light of its
limitations. First, the average number of EFWs measured
per fetus was low as a result of higher-than-expected
rates of participant non-attendance and limited avail-
ability of sonographers, and not all newborns had BWs
collected within 24 hours of delivery. This may under-
estimate SGA prevalence, since fetal growth is thought
to be pulsatile and catch-up growth may occur follow-
ing an insult (e.g. treated malaria infection) [14]. Sec-
ond, we included BWs in the analysis and defined SGA
as any weight below the 10th centile of the Hadlock
standard. The use of this nomogram, derived from a
Caucasian middle-class cohort, may overestimate SGA
amongst differing ethnic groups, as may the inclusion
of BWs [24]. Third, despite efforts to closely monitor
the malaria infection burden it is possible that infec-
tions were missed. Fourth, we used opportunistic sam-
pling of our trial cohort for ultrasound studies, which
may have introduced unintentional bias. Fifth, the trial
setting (with different antimalarial regimes used) may
have resulted in differential effects on parameters of
Table 3 Maternal characteristics and malaria infection, and associations with SGA and fetal weight z-scores
% (N) RR (95% CI) or coefficient
[95% CI]
P Adjusted RR (95% CI) or coefficient
[95% CI]
P
Weight measurements 1,504
SGA measurements 379
Measurement-specific
Any malaria infection 21.1 (318/1,504) 1.36 (1.12, 1.65) 0.002 1.13 (0.95, 1.34) 0.172
−0.10 [−0.23, 0.03] 0.115 −0.06 [−0.19, 0.07] 0.372
Recent infection (<6 wks) 10.5 (158/1,504) 1.06 (0.80, 1.41) 0.680 1.03 (0.81, 1.32) 0.799
0.06 [−0.08, 0.20] 0.403 0.06 [−0.08, 0.21] 0.375
Cumulative infectiona
1 18.6 (280/1,504) 1.24 (1.00, 1.52) 1.12 (0.93, 1.34)
≥2 2.5 (38/1,504) 2.25 (1.63, 3.09) <0.001 1.18 (0.85, 1.63) 0.389
−0.09 [−0.22, 0.05] −0.05 [−0.18, 0.09]
−0.25 [−0.53, 0.04] 0.155 −0.13 [−0.41, 0.16] 0.581
Recent IPTp 42.4 (637/1,504) 0.22 (0.17, 0.29) <0.001 0.79 (0.57, 1.08) 0.140
0.20 [0.12, 0.28] <0.001 0.16 [0.04, 0.27] 0.010
Low gestational weight gain 23.8 (173/735) 1.15 (0.92, 1.43) 0.237 1.21 (1.01, 1.45)b 0.042
−0.16 [−0.35, 0.03] 0.095 −0.18 [−0.37, 0.00]b 0.051
At enrolment
Malaria infection 14.9 (100/671) 1.17 (0.92, 1.49) 0.207 1.12 (0.91, 1.36) 0.285
−0.13 [−0.30, 0.04] 0.137 −0.11 [−0.27, 0.05] 0.186
MUAC <22 cm 13.8 (91/658) 1.48 (1.20, 1.82) <0.001 1.51 (1.29, 1.76) <0.001
−0.19 [−0.36, −0.02] 0.031 −0.18 [−0.34, −0.01] 0.038
Body mass index <18.5 kg/m3 5.1 (34/664) 1.29 (0.98, 1.69) 0.074 1.33 (0.95, 1.86) 0.103
−0.19 [−0.36, −0.02] 0.031 −0.11 [−0.37, 0.16] 0.436
Height <150 cm 21.2 (141/665) 1.31 (1.10, 1.57) 0.003 1.27 (1.04, 1.55) 0.009
−0.19 [−0.36, −0.02] 0.031 −0.17 [−0.31, −0.03] 0.016
Haemoglobin <90 g/L 22.8 (148/650) 1.12 (0.92, 1.37) 0.266 1.27 (1.06, 1.51) 0.009
0.02 [−0.13, 0.16] 0.840 0.01 [−0.13, 0.15] 0.880
Note. RR, risk ratio, CI, confidence interval, IPTp, intermittent preventive treatment in pregnancy, MUAC, mid-upper arm circumference. P <0.05 highlighted in bold.
Adjusted analyses included gravidity and gestational age at fetal weight measurement as covariates.
a P for comparison across groups.
b Additionally adjusted for gestational age at first maternal weight measurement, time difference between maternal weight measurements.
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potential confounders of the observed relationships
may have been measured and evaluated (e.g. HIV, hel-
minth infection, micronutrient deficiencies).
AC is an important screening tool for FGR [25,26].
We used EFW rather than AC (or a combination of
both) in our analyses for several reasons. First, it in-
creases comparability of our findings with other malaria
studies [13,16]. Second, many AC measurements were
measured postnatally and not by ultrasound; they were
not subject to the same stringent QC that ultrasound
and birth weight measures were. Third, malaria in early
pregnancy and undernutrition have been associated with
reduced skeletal growth [11].Indicators of maternal macronutritent undernutrition
were strongly associated with low fetal weight or fetal
weight gain. Interventions to improve maternal macronutri-
ent nutritional status including nutritional supplementation
merit evaluation in PNG and elsewhere [27]. Anaemia at
enrolment was associated with suboptimal fetal weight gain.
Anaemia tended to be more common amongst women
with concomitant malaria (29.9% vs 21.5%, P = 0.070) but
nutritional deficiencies and intestinal helminth infections
may also contribute to its aetiology. Although it has been
proposed that iron supplementation may increase the risk
of infection (including malaria) in iron-replete women [28],
it is likely that most anaemic women in PNG are iron-
deficient, and require supplementation.
Table 4 Maternal characteristics and malaria infection, and associations with low fetal weight and change in weight
z-scores (Δz)
% (N) RR (95% CI) or
coefficient [95% CI]
P Adjusted RR (95% CI) or
coefficient [95% CI]
P
Number of intervals 833
Episodes of low fetal weight gain 208
Interval-specific
Malaria infection before interval 20.7 (172/833) 1.18 (0.87, 1.58) 0.287 1.13 (0.84, 1.52) 0.431
- 0.12 [−0.30, 0.06] 0.179 −0.11 [−0.29, 0.07] 0.232
Malaria infection during interval 8.2 (68/833) 1.08 (0.72, 1.62) 0.711 0.94 (0.62, 1.44) 0.774
−0.06 [−0.30, 0.17] 0.607 −0.04 [−0.28, 0.19] 0.721
At enrolment
Malaria infection 13.1 (69/527) 1.18 (0.85, 1.63) 0.324 1.10 (0.79, 1.54) 0.561
−0.06 [−0.26, 0.14] 0.556 −0.04 [−0.24, 0.16] 0.683
MUAC <22 cm 13.6 (70/516) 1.22 (0.93, 1.59) 0.145 1.12 (0.93, 1.59) 0.156
−0.18 [−0.36, 0.01] 0.057 −0.16 [−0.34, 0.03] 0.095
Body mass index <18.5 kg/m3 4.6 (24/522) 2.10 (1.62, 2.71) <0.001 2.08 (1.62, 2.68) <0.001
−0.39 [−0.69, −0.08] 0.014 −0.35 [−0.66, −0.05] 0.024
Height <150 cm 21.4 (115/522) 1.26 (0.97, 1.63) 0.080 1.18 (0.92, 1.53) 0.198
−0.12 [−0.28, −0.04] 0.150 −0.09 [−0.25, 0.07] 0.256
Haemoglobin <90 g/L 22.3 (115/515) 1.18 (0.91, 1.52) 0.213 1.17 (0.91, 1.51) 0.225
−0.22 [−0.37, −0.06] 0.006 −0.18 [−0.34, −0.03] 0.021
Note. IPTp, intermittent preventive treatment in pregnancy; MUAC, mid-upper arm circumference. P <0.05 highlighted in bold. Adjusted analyses included gravid-
ity and length of interval as covariates.
Unger et al. BMC Pregnancy and Childbirth  (2015) 15:83 Page 7 of 8We did not observe effect measure modification of the
malaria-FGR relationship by maternal nutritional status
[16], nor were we able to unequivocally demonstrate a
deleterious effect of malaria infection on fetal growth
unlike other studies [11]: previous malaria infection was
associated with SGA in unadjusted, but not adjusted
analyses. This may be because we lack power due to low
infection prevalence (reduced further following enrol-
ment by both trial interventions) [17], and comparatively
few malaria screening visits and weight measurements,
thereby potentially missing infections or episodes of sub-
optimal fetal growth. Of malaria infections, many were
submicroscopic, and their role in causing FGR and LBW
remains poorly understood. P. vivax caused one third of
infections in our cohort. Early P. vivax infection has
been associated with reduced z-scores and anthropomet-
ric measurements [11] [12], but mechanisms are less
well understood than for P. falciparum, and its deleteri-
ous effect on fetal growth may be smaller. Most infec-
tions were detected at enrolment. Although there is
increasing evidence that malarial infection in early preg-
nancy can affect fetal growth [29], compensatory pro-
cesses such as adaptive villous angiogenesis, and catch-up
growth, may have mitigated the deleterious effect on fetal
growth of some of these infections in the context of early
treatment (trial intervention), insecticide-treated bed nets,and close clinical monitoring provided as part of the ori-
ginal trial [13,30]. The risk of SGA secondary to malaria
became non-significant in models adjusting for GA at
weight measurement. Inclusion of GA as a confounder
was necessary because the risk of measuring small in-
creased (linearly) as pregnancy progressed and GA at
weight measurement differed between participants. Al-
though we did not corroborate findings of other ultra-
sound studies, prevention and prompt treatment of
malarial infection in pregnancy will reduce LBW and
forms an essential part of prenatal care in malaria-endemic
areas. Recent receipt of IPTp was associated with increased
weight z-scores in this cohort, suggesting it (at least) tem-
porarily prevents FGR through preventing and treating pla-
cental malaria or through other, unknown mechanisms
that improve fetal growth.
Conclusions
Over 40% of pregnant women living in a malaria-endemic
area in rural PNG had babies that measured SGA in utero
or at delivery. Maternal macronutrient undernutrition,
short stature and anaemia negatively affected fetal growth,
while the low prevalence of malaria may explain its lack of
influence on fetal growth. Antenatal interventions to im-
prove nutritional status throughout pregnancy are likely
to reduce the risk of FGR and LBW in PNG.
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